AMPLIFIER THERAPEUTICS Trademark
Trademark Overview
On Tuesday, January 3, 2023, a trademark application was filed for AMPLIFIER THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AMPLIFIER THERAPEUTICS trademark a serial number of 97739348. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, April 3, 2024. This trademark is owned by Cambrian BioPharma, Inc.. The AMPLIFIER THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
research and development in the field of pharmacologic compounds affecting the cardiovascular system, pharmacologic compounds that produce the benefits of exercise, small molecules, and pharmacologic compounds affecting metabolic system; scientific research for medical purposes in the field of pharmacologic compounds affecting the cardiovascular system, pharmacologic compounds that produce the benefits of exercise, small molecules, and pharmacologic compounds affecting metabolic system
General Information
| Serial Number | 97739348 |
| Word Mark | AMPLIFIER THERAPEUTICS |
| Filing Date | Tuesday, January 3, 2023 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, April 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 7, 2024 |
Trademark Statements
| Disclaimer with Predetermined Text | "THERAPEUTICS" |
| Goods and Services | research and development in the field of pharmacologic compounds affecting the cardiovascular system, pharmacologic compounds that produce the benefits of exercise, small molecules, and pharmacologic compounds affecting metabolic system; scientific research for medical purposes in the field of pharmacologic compounds affecting the cardiovascular system, pharmacologic compounds that produce the benefits of exercise, small molecules, and pharmacologic compounds affecting metabolic system |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 26, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | AMPLIFIER TX AB |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | UMEA 90326
SE |
| Party Name | Cambrian BioPharma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10003 |
Trademark Events
| Event Date | Event Description |
| Monday, April 1, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, January 27, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, January 26, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 26, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, October 20, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Friday, October 20, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, July 26, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, July 26, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, July 26, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, July 26, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, July 26, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, July 26, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, July 7, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, May 3, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, January 26, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, January 6, 2023 | NEW APPLICATION ENTERED |
